Indeed, simultaneous inhibition of GLI with GANT58 and RSK2 with SL0101 has been reported to synergistically reduce GLI2 levels, enhancing apoptosis of multiple myeloma cells (Liu et al., 2014). Here, RPS6KA3 is linked to plasma cell myeloma.